medolight byBioptron
The third-generation device for light therapy, utilizing the latest scientific advancements.
Survey
As the manufacturer of the Z4L device, as part of the PMS procedure (post-market surveillance), we are obliged to provide information/a survey for customers, through which you can submit feedback regarding the device’s performance.
medolight byBioptron!
Medolight by Bioptron is used for pain relief, accelerating healing, reducing inflammation, and disease prevention. It is intended for both home and professional use. Clinical studies have confirmed that it safely alleviates joint and muscle pain, increases blood circulation, stimulates the immune system, improves metabolism, helps prevent cardiovascular diseases, and contributes to overall well-being. It operates painlessly, is easy to use, and 100% safe.
Download the Medolight by Bioptron manual
Medolight by Bioptron is approved as a medical device according to the European Union Directive 93/42/EEC.
Indications and Contraindications
Indications and Contraindications, as well as Limitations of Use for the Medolight Z4L Device.
Indications
- Limb pain
- Lower back pain
- Joint pain
- Wound healing after aesthetic medicine procedures
- Adjunctive treatment after injuries and surgeries
- Supportive treatment for resistant chalazion
- Treatment of nipple fissures in breastfeeding mothers
- Stress burden
- Bedsores
- Postoperative period (laser cryosurgery, general and plastic surgeries)
- Overstrain from sports activities
- Postoperative wounds
- Sciatica
- Lowered immunity
- Aging skin
- Acne
- Difficult-to-heal wounds (bites, diabetes, gangrene)
- Trophic leg ulcers
- Sleep disorders
- Arthritis, osteoarthritis
- Varicose veins of the lower legs, chronic thrombophlebitis
Contraindications and Limitations
- Patients with epilepsy should consult a doctor before starting light therapy.
- Pregnant women should consult a doctor before starting light therapy.
- Patients with certain thyroid conditions (as assessed by the attending physician).
- History of any skin cancers.
- Systemic lupus erythematosus.
- Use of medications that increase sensitivity to light.
- Porphyria
- Ophthalmic diseases, unless treatment is initiated with the approval of a doctor
- Choroby okulistyczne, chyba że leczenie jest wdrożone za zgodą lekarza
NOTE: Before starting operation, carefully read the user manual and follow the recommendations, warnings, and instructions contained therein.
Manufacturer and distributor: ZEPTER International Poland Sp. z o.o., ul. Domaniewska 37, 02-672 Warsaw
Certificates / Declarations
The owner of the website is Zepter International Poland sp. z o.o., 02-672 Warsaw, ul. Domaniewska 37, registered in the National Court Register – Business Register maintained by the District Court for the capital city of Warsaw, 13th Commercial Division of the National Court Register under the number KRS 0000107635, with a share capital of 224,500 PLN, VAT number (NIP) 526-020-01-87